Belite Bio, Inc (BLTE)
NASDAQ: BLTE · Real-Time Price · USD
161.06
-0.88 (-0.54%)
At close: Aug 21, 2026, 4:00 PM EDT
160.71
-0.35 (-0.22%)
After-hours: Aug 21, 2026, 7:30 PM EDT

Belite Bio Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
6,4866,0011,9481,263750-
Market Cap Growth
211.49%207.98%54.32%68.44%--
Enterprise Value
5,9945,7261,8611,221701-
Last Close Price
161.06159.9663.1045.7530.14-

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
8.357.7913.3613.9618.06-
P/TBV Ratio
8.357.7913.3713.9618.06-

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-0.000.000.010.02-
Net Debt / Equity Ratio
--0.64-0.99-0.96-0.99-1.04
Net Debt / EBITDA Ratio
-5.863.632.773.231.78
Net Debt / FCF Ratio
-13.244.932.923.482.30
Quick Ratio
-49.9024.0924.5020.0110.61
Current Ratio
33.5650.0224.3124.7620.3510.66
Return on Equity (ROE)
-22.10%-16.94%-30.60%-47.95%-43.45%-46.60%
Return on Assets (ROA)
-15.65%-11.29%-20.26%-28.50%-25.59%-27.78%
Return on Capital Employed (ROCE)
-15.30%-10.90%-27.40%-34.80%-30.40%-58.60%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-1.58%-1.29%-1.85%-2.50%-1.69%-
FCF Yield
-0.57%-0.62%-1.51%-2.37%-1.58%-
Buyback Yield / Dilution
-17.91%-9.82%-14.83%-33.12%-108.74%-8.87%
SEC Filings: 10-K · 10-Q